N/A(healthy adults)
Conditions
Interventions
Intake of test beverage for 2 weeks ->
Washout for 2 weeks or more ->
Intake of placebo beverage for 2 weeks
Intake of placebo beverage for 2 weeks ->
Intake of test beverage for 2 weeks
Sponsors
Morinaga & Co.,Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) Females aged between 50 and 64 years old who feel fatigue (2) Subjects who have received sufficient explanation about the purpose and content of the study, have the ability to consent, voluntarily volunteered to participate, and agreed to participate it by signing the written informed consent
Exclusion criteria
Exclusion criteria: (1) Subjects who have history of diabetes, liver disease, kidney disease, gastrointestinal disease, heart disease, respiratory disease, peripheral vascular disease, or other serious disease (2) Subjects who are judged by the principal investigator to have abnormal electrocardiogram (3) Subjects who have injuries or illnesses that interfere with ergometer exercise (4) Subjects who are under medical treatment (5) Subjects who are allergic to food and drugs (6) Subjects who cannot avoid taking health foods (including Food for Specified Health Uses, and Foods with Function Claims) and designated quasi-drugs during the test period (7) Subjects who are taking medication (including OTC and prescription drugs) (8) Subjects who have excessive alcohol consumption, or not avoid consumption of alcohol from the day before the test until the end of the test (9) Subjects who are planning to get pregnant after the day of informed consent or are currently pregnant and lactating (10) Subjects who have participated or are planning to participate in other clinical studies during the current study (11) Subjects who are judged ineligible at the discretion of the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue index using questionnaires after 2-week ingestion of test beverage | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness support Co., Ltd. Clinical trial Division
Outcome results
None listed